Subjective ratings of actual depression, anxiety, and stress were highly significantly negatively associated with current adiponectin levels in HSS patients during the second treatment phase, i.e., BMI ≥ 16 kg/m2. This evidence concerns the gene ADIPOQ and depressive disorder.